Anew Health is a Hong Kong-based pain management and wellness services company operating under the "ANKH" brand. Founded in 2007, Anew Health provides non-invasive, non-pharmacological pain therapies targeting adults with chronic musculoskeletal conditions such as back pain, knee osteoarthritis, and joint pain. The core service is a proprietary treatment framework called "RDS+" (Restore, Detox, and Strengthen), which combines Traditional Chinese Medicine theory with energy-based devices sourced from Germany, South Korea, and Japan. Therapists apply laser, radiofrequency, electromagnetic, ultrasound, and infrared technologies to address pain symptoms. Anew Health sells multi-session prepaid packages, typically lasting one to five years, with clients visiting two to three times per week. Customers pay the full contract value upfront, and revenue is recognized as sessions are delivered. The company serves roughly 10,000 clients annually, each spending approximately US$6,500 on average, making this a high-ticket, relationship-driven business. Anew Health operates three service centers in prime Hong Kong commercial locations, with a fourth opened in 2025. Gross margins are high at roughly 67%, but operating leverage is constrained by fixed service center costs and heavy marketing spend, which ran approximately US$7.8M in FY2025. The company is pursuing growth through additional Hong Kong locations, international expansion into markets including Singapore and the U.S., and development of portable home-use energy-based treatment devices. Anew Health is seeking to list on the Nasdaq Capital Market under the ticker "AVG."